Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what representations he has received on the increase in prescribing of anti-psychotics to people with dementia during the covid-19 outbreak.
Stakeholders have made representations about an increase in the prescribing of anti-psychotic drugs to people with dementia during our regular discussions about the impact of the pandemic on people living with dementia and their carers.
NHS England and NHS Improvement continue to monitor the monthly data published by NHS Digital on the prescribing of anti-psychotic medication for people diagnosed with dementia and continue to have regular conversations with regional clinical network leads and local services to understand the patterns in prescribing and potential reasons for trends being seen.